tropical infections

Tropical infectious diseases are indigenous to tropical and subtropical countries that are affecting the human population. According to WHO, countries such as Africa, Southeast Asia, Eastern Mediterranean regions are highly burdened with disease prevalence showing the highest morbidity and mortality. The diseases magnitude can be attributed to the decreased resources, population growth, climatic changes, failure of public health intervention, lack of medical care access, economic collapse, and emerging drug resistance. Explore advanced search options by clicking CLINICAL DIAGNOSIS, ICD-10-CM CODES, and LABORATORY PARAMETERS.

Show rows
|< < of > >|

Tropical infections are highly prevalent in more impoverished and developing countries due to low economic living conditions, inadequate sanitation facilities, lack of safe drinking water, unhygienic human settlements, and lack of medical care access. However, the reduction of disease incidence can be achieved by improved awareness, advanced treatment options, and implementation of strict prevention and control measures.


Major Tropical Infections:

Common tropical infectious diseases are malaria, Dengue fever, Chikungunya, West Nile disease, Chagas disease, tuberculosis, Zika virus disease, etc. It encompasses diverse pathogenic infections caused by viruses, bacterias, fungus, and parasites. Tropical diseases are primarily vector-borne illnesses and transmitted to humans through mosquitos, flies, animals, etc. Therefore, tackling tropical infection has always been a more significant challenge for physicians in low and middle-income countries. Resulting from globalization, migration and increased tourism to tropical countries, the incidence rate of diseases like Malaria, Dengue, etc have increased in western world. Therefore, the present scenario demands more reliable, accurate and quick diagnostic tools for early detection and mitigation of disease.

Need for Extensive Research:

Intensive research is crucial for every disease control program. The growing prevalence of the various tropical diseases alarms the national health systems of various developing nations for more efficient public health interventions for effective disease control and eradication. The rising incidence of diseases demands more efficient, quicker, and reliable diagnostic and therapeutic advancements. The emergence of newer infections increases the enormous scope for molecular biology, infection biology, diagnostic, health economic, and therapeutic research. Promotion of newer research is essential for compacting present tropical infections and mitigating potential unique infections emerging in the future.

Central Biohub: Tailoring Sophisticated Solutions for Biosample Procurement

Central BioHub presents a comprehensive collection of biospecimens derived from patients with Malaria, Tuberculosis, Dengue fever, Chikungunya, West Nile disease, Zika virus. Promoting scope for advanced research on tropical infections, we supply hyper-annotated, high-quality human serum, plasma, and saliva samples of diseased individuals to researchers and scientists worldwide. We offer a broad spectrum of tropical disease samples ethically derived from suspected and clinically confirmed patients of all ages, gender, and ethnicity. To validate the diseases, the biospecimens are subjected to specific antibody testing and PCR testing, and are preserved in complete frozen condition at our biobank.
Marking an end to the tedious biospecimen procurement process, Central BioHub provides a user-friendly, open-access, convenient online marketplace for purchasing ideal human biospecimens for the tropical infections. Research scientists can select and buy the biosamples of tropical diseases within no time. Enhancing customer experience, our scientific experts will help you with every step of the biosample acquisition process.